What is synthetic biology used for?

Synthetic biology is used across six major sectors: (1) Therapeutics -- gene therapies (CRISPR Casgevy for sickle cell), cell therapies (CAR-T), mRNA vaccines, and AI-designed biologics. (2) Agriculture -- nitrogen-fixing microbes (Pivot Bio), gene-edited crops (Inari), and biopesticides. (3) Food & Nutrition -- precision fermentation for dairy proteins (Perfect Day), animal-free collagen, and cultivated meat. (4) Industrial Chemicals -- bio-based solvents, hydrogen peroxide (Solugen), and bioplastics. (5) Materials -- spider silk (Bolt Threads), mycelium leather (MycoWorks), and bio-based dyes. (6) Energy & Environment -- carbon capture via engineered microbes (LanzaTech), biofuels, and bioremediation.

What are the biggest synthetic biology products on the market?

The largest commercial synbio products in 2026 include: Casgevy (CRISPR Therapeutics / Vertex, first approved CRISPR gene therapy), COVID-19 mRNA vaccines (BioNTech / Moderna, $50B+ cumulative revenue), Impossible Burger (heme protein via precision fermentation), Perfect Day whey protein (used in Brave Robot ice cream and other brands), Solugen bio-based chemicals (distributed in major industrial channels), and Pivot Bio nitrogen-fixing microbes (applied on millions of US crop acres). The synbio therapeutics market alone is projected to exceed $30B by 2028.

How is synthetic biology used in medicine?

Synthetic biology has transformed medicine across multiple modalities. Gene editing therapies use CRISPR to correct genetic mutations directly (Casgevy for sickle cell disease, Intellia for transthyretin amyloidosis). Cell therapies engineer immune cells to fight cancer (CAR-T therapies from Kite/Gilead, Novartis, and next-gen platforms like ArsenalBio). mRNA technology programs cells to produce therapeutic proteins (vaccines, cancer immunotherapy, rare disease treatments). AI-designed biologics use computational protein engineering to create novel antibodies and enzymes (Absci, Generate Biomedicines). As of 2026, there are 70+ CRISPR clinical trials and 200+ cell therapy trials active globally.

What is precision fermentation and what products does it make?

Precision fermentation uses engineered microorganisms (yeast, bacteria, fungi) as tiny factories to produce specific proteins, fats, or chemicals. The microbes are programmed with synthetic DNA to produce target molecules, then grown in fermentation tanks at scale. Products include: whey and casein dairy proteins (Perfect Day), collagen (Geltor), egg proteins (The EVERY Company), heme for plant-based meat (Impossible Foods), industrial enzymes, and pharmaceutical ingredients. The precision fermentation market is projected to reach $36B by 2030, with dairy proteins as the leading application.

How does synthetic biology help with climate change?

Synbio addresses climate change through multiple pathways: (1) Carbon capture -- LanzaTech engineers bacteria that convert industrial CO2 emissions into ethanol and other chemicals. (2) Sustainable agriculture -- Pivot Bio nitrogen-fixing microbes reduce synthetic fertilizer use (a major emissions source). (3) Bio-based materials -- replacing petroleum-derived plastics and chemicals with fermentation-produced alternatives (Solugen, Genomatica). (4) Sustainable food -- precision fermentation produces dairy and meat proteins with 85-97% lower carbon footprint vs. animal agriculture. (5) Biofuels -- engineered algae and microbes produce next-generation fuels. (6) Bioremediation -- engineered organisms break down environmental pollutants.

What is the market size of synthetic biology?

The global synthetic biology market was valued at approximately $15-18 billion in 2025 and is projected to reach $50-80 billion by 2030, depending on the definition and scope. Therapeutics is the largest segment (gene therapy, cell therapy, mRNA), followed by industrial biotechnology (chemicals, materials, fuels) and agriculture. Key growth drivers include CRISPR therapy approvals, AI protein design commercialization, precision fermentation scale-up, and increasing corporate demand for sustainable bio-based products. The sector has attracted over $7 billion in venture capital as tracked by synbiointel.com.

What Can Synthetic Biology Do? Every Application and Use Case (2026)

Synthetic biology is no longer a research concept -- it is a commercial reality producing FDA-approved gene therapies, animal-free dairy proteins, bio-based industrial chemicals, and nitrogen-fixing crops deployed on millions of acres. This page maps every major synbio application category with real companies, real products, and real market impact. We track 55+ companies across 5 sectors and 22 distinct application areas.

Application Categories

Distinct Applications

Companies Tracked

55+

Last Updated

Mar 2026

RxTherapeutics & Medicine5 applications

Application	Example Product / Use	Key Companies
Gene Therapy (CRISPR)	Casgevy (sickle cell disease cure)	CRISPR Therapeutics, Intellia, Beam, Editas
Cell Therapy (CAR-T)	Engineered T-cells targeting cancer	ArsenalBio, Sana Biotechnology, Senti Bio
mRNA Therapeutics	Programmable RNA medicines & vaccines	Moderna, BioNTech, Strand Therapeutics
AI-Designed Biologics	Computationally designed antibodies	Absci, Generate Biomedicines, EvolutionaryScale
Microbiome Therapeutics	Engineered gut bacteria as drugs	Seres Therapeutics, Synlogic

AgAgriculture4 applications

Application	Example Product / Use	Key Companies
Nitrogen Fixation	Microbes that replace synthetic fertilizer	Pivot Bio
Gene-Edited Crops	Drought-resistant, higher-yield seeds	Inari, Pairwise
Biopesticides	Microbial pest control	AgBiome, Vestaron
Animal Health	Engineered vaccines, diagnostics	Elanco (synbio pipeline)

FdFood & Nutrition4 applications

Application	Example Product / Use	Key Companies
Dairy Proteins	Animal-free whey & casein	Perfect Day, New Culture
Egg Proteins	Fermentation-derived egg whites	The EVERY Company
Heme / Flavors	Plant-based meat flavoring	Impossible Foods
Sweeteners	Rare sugar production via fermentation	Amyris (legacy IP)

ChIndustrial Chemicals & Materials5 applications

Application	Example Product / Use	Key Companies
Bio-based Chemicals	H2O2, solvents, organic acids	Solugen, Genomatica
Carbon Recycling	CO2/CO to ethanol & chemicals	LanzaTech
Bioplastics	PHA, PLA alternatives	Danimer Scientific, Newlight
Spider Silk & Fibers	Recombinant structural proteins	Bolt Threads
Mycelium Materials	Leather, packaging, building materials	MycoWorks, Ecovative

EnEnergy & Environment4 applications

Application	Example Product / Use	Key Companies
Biofuels	Engineered algae & microbial fuel production	Synthetic Genomics, Viridos
Carbon Capture	Engineered organisms that sequester CO2	LanzaTech, Cemvita
Bioremediation	Microbes that degrade pollutants	Allonnia
Biosensors	Engineered organisms that detect contaminants	Various academic spin-outs

Market Size by Segment (2026 Estimates)

Gene & Cell Therapy$25-30B25-30% CAGR

mRNA Therapeutics$15-20B15-20% CAGR

Industrial Biotechnology$10-15B12-15% CAGR

Precision Fermentation$3-5B35-45% CAGR

Agricultural Synbio$2-4B20-25% CAGR

THE BOTTOM LINE

Synthetic biology has crossed the commercialization threshold. The first CRISPR gene therapy is FDA-approved. Precision fermentation proteins are in grocery stores. Bio-based chemicals are displacing petroleum feedstocks at industrial scale. Nitrogen-fixing microbes are on millions of acres of US farmland.

The common thread across every application category is programmability: the ability to read, write, and edit biological code enables solutions across healthcare, food, materials, energy, and agriculture. The convergence of AI with biology is accelerating every category -- AI designs the molecules, synbio manufactures them.

The total addressable market for synthetic biology applications exceeds $500 billion when you include all the industries it touches. The question is no longer whether synbio works, but how fast it scales.

Frequently Asked Questions// synthetic biology applications

RELATED INTELLIGENCE